About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
Previous Close | $5.42 | Open | $5.43 |
Volume | 577.9K | Market Cap | 4.23B |
Yield | Last Dividend |
Adaptimmune Therapeutics plc (NASDAQ:ADA... | 5:57 AM |
Adaptimmune Therapeutics plc (NASDAQ:ADAP) CEO Adrian Rawcliffe sold 9,879 shares of the firm???s stock in a transaction dated Tuesday, January 19th. ... |
Adaptimmune Therapeutics plc (NASDAQ:ADA... | 01/14/21 |
Adaptimmune Therapeutics plc (NASDAQ:ADAP) CEO Adrian Rawcliffe sold 2,707 shares of the stock in a transaction on Tuesday, January 12th. The stock wa... |
Adaptimmune Therapeutics plc (NASDAQ:ADA... | 01/06/21 |
Adaptimmune Therapeutics plc (NASDAQ:ADAP) COO William C. Bertrand, Jr. sold 3,499 shares of the company???s stock in a transaction that occurred on M... |
Adaptimmune Therapeutics plc (NASDAQ:ADA... | 12/18/20 |
Adaptimmune Therapeutics plc (NASDAQ:ADAP) COO William C. Bertrand, Jr. purchased 207,000 shares of the stock in a transaction dated Monday, December ... |
The Week Ahead In Biotech: Supernus, San... | 11/08/20 |
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a change of gua... |
50 Biggest Movers From Friday | 10/26/20 |
Gainers Marin Software Incorporated (NASDAQ: MRIN ) shares climbed 62.7% to close at $3.45 on Friday, reversing from Thursday's selloff. Strattec Secu... |
Adaptimmune to Report Q3 Financial Resul... | 10/22/20 |
PHILADELPHIA and OXFORDSHIRE, U.K., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat??? |
Adaptimmune Therapeutics (NASDAQ:ADAP) S... | 10/21/20 |
Adaptimmune Therapeutics PLC ??? (NASDAQ:ADAP)???s share price traded down 16% on Wednesday . The company traded as low as $4.51 and last traded at $4... |
Adaptimmune to Report Q2 Financial Resul... | 07/22/20 |
PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy t... |
The Daily Biotech Pulse: FDA Nod For Roc... | 06/02/20 |
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Adap... |
Adaptimmune Announces $11/ADS Pricing; S... | 06/02/20 |
Biopharma Adaptimmune Therapeutics (ADAP) has now announced the pricing of an underwritten public offering of 20,500,000 of its American Depositary Sh... |
Are Options Traders Betting on a Big Mov... | 06/01/20 |
Investors need to pay close attention to Adaptimmune Therapeutics (ADAP) stock based on the movements in the options market lately. |
Adaptimmune's stock tumbles after plans ... | 06/01/20 |
Shares of Adaptimmune Therapeutics PLC undefined tumbled 11% in premarket trading Monday, after the biopharmaceutical company focused on cancer treatm... |
Adaptimmune Shares Nearly Double On Prom... | 05/29/20 |
Adaptimmune Therapeutics PLC ??? ADR (NASDAQ: ADAP) shares were advancing strongly Friday following an updated clinical readout from the ??? |
What Makes Adaptimmune Therapeutics PLC ... | 04/28/20 |
Adaptimmune Therapeutics PLC (ADAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks R... |
Adaptimmune Therapeutics : Chairman Lett... | 04/22/20 |
Adaptimmune Therapeutics PLC Registered office: 60 Jubilee Avenue, Milton Park Abingdon, Oxfordshire OX14 4RX, U.K. ??? | April 22, 2020 |
Has Adaptimmune Therapeutics (ADAP) Outp... | 02/05/20 |
Is (ADAP) Outperforming Other Medical Stocks This Year? |
Adaptimmune Therapeutics plc (ADAP) Shar... | 02/03/20 |
As of late, it has definitely been a great time to be an investor Adaptimmune Therapeutics plc (ADAP). |
The Daily Biotech Pulse: Nektar Withdraw... | 01/15/20 |
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs o... |
Adaptimmune Soars 250% On Positive Initi... | 01/13/20 |
Shares of smid-cap biotech Adaptimmune Therapeutics PLC ??? ADR (NASDAQ: ADAP ) were skyrocketing Monday following a presentation at the 38t |
The Daily Biotech Pulse: Amarin Gets Una... | 11/15/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) ... |
Cowen Reaffirms ???Buy??? Rating for Ada... | 11/11/19 |
Cowen reaffirmed their buy rating on shares of Adaptimmune Therapeutics (NASDAQ:ADAP) in a research note issued to investors on Thursday, AnalystRatin... |
Is Adaptimmune Therapeutics plc (ADAP) I... | 10/31/19 |
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge ... |
The Daily Biotech Pulse: Melinta Crosses... | 10/25/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 24) ... |
The Daily Biotech Pulse: FDA Approves Cl... | 10/09/19 |
The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-we... |
The Daily Biotech Pulse: Arbutus Halts H... | 10/04/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Ap... |
Adaptimmune (ADAP) Gets Orphan Drug Stat... | 09/10/19 |
Adaptimmune Therapeutics (ADAP) gets Orphan Drug Designation for SPEAR T-cells targeting MAGE-A4 (ADP-A2M4 program) for the treatment of soft tissue s... |
The Daily Biotech Pulse: Roche Snags Dou... | 08/16/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) ... |
The Daily Biotech Pulse: Mallinkckrodt's... | 08/15/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) ... |
The Daily Biotech Pulse: Jazz Goes Shopp... | 08/13/19 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 12) ... |
Buy rating | 11/05/20 |
SVB Leerink maintains Market Perform rating and lowers Price Target from $10.00 to $6.00 |
Date | 2020-11-05 (BMO) | Est. (EPS/Rev.) | ($0.25)/ 870K |
Actual (EPS/Rev.) | $-0.04/ $1.19 M | EPS (TTM) | 0 |
Total Revenue | $1.3B | Total Liabilities | $2.1B |
Cost of Revenue | $2.5B | Total cash flow | $3.2 |
Total Assets | $29.98B |
% Insider | 12.52% | % Institutional | 76.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Service Name | Trader | % Success | |
---|---|---|---|
Tech Trades | Tech Trades | 81.00 % | Follow |
Basura | Monkey Business | 59.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.